Catalyst Wire Dossier Catalyst Wire Dossier

LHRH

leuprolin or luteinizing hormone-releasing hormone analogue
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LHRH, covering 2020-03-18 to 2020-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) [Phase 2]

See pricing